Fluicell
0,047
SEK
+14,08 %
Mindre end 1K følgere
FLUI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
+14,08%
-5,62%
+14,63%
+0,43%
-37,67%
-65,89%
-98,37%
-96,71%
-98,51%
Fluicell is a biotechnology company. The company conducts research and development in processing the composition of cells in the development of new pharmaceuticals. The company has developed a product portfolio consisting of patented research instruments, which are used to study, analyze and finally process cells. In addition, there is expertise in 2D / 3D printing. Fluicell was founded in 2012 and is headquartered in Gothenburg.
Læs mereMarkedsværdi
22,6 mio. SEK
Aktieomsætning
84,12 t SEK
Omsætning
3,34 mio.
EBIT %
-804,79 %
P/E
-
Udbytteafkast, %
-
Finanskalender
21.3
2025
Årsrapport '24
9.5
2025
Delårsrapport Q1'25
14.5
2025
Generalforsamling '25
Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
BioStock: 2021 represents beginning of new era for Fluicell
BioStock: Fluicell dives into regenerative medicine field
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools